FAQs with an ID expert on COVID mRNA Vaccines
No me gusta!
The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.
In this Hippo Education bonus, Dr. Matthieu DeClerck and Dr. Manie Beheshti, an infectious disease specialist, answer common questions that clinicians have regarding the new mRNA vaccine, including how mRNA vaccines work, concerns about what we know and don’t know, and how to best approach patients.
Published 12/14/2020
References:
-
Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13. PMID: 32800805; PMCID: PMC7423510.
-
Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020 Oct 13;5(1):237. doi: 10.1038/s41392-020-00352-y. PMID: 33051445; PMCID: PMC7551521.
-
Lowe, Derek. “Get Ready for False Side Effects.” In the Pipeline, 4 Dec. 2020, . blogs.sciencemag.org/pipeline/archives/2020/12/04/get-ready-for-false-side-effects
-
Abbasi J. COVID-19 and mRNA Vaccines—First Large Test for a New Approach. JAMA. 2020;324(12):1125–1127. doi:10.1001/jama.2020.16866
-
FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine Sponsor: Pfizer and BioNTech.; 2020. https://www.fda.gov/media/144245/download
- Widge AT, Rouphael NG, Jackson LA, et al. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. New England Journal of Medicine. Published online December 3, 2020. doi:10.1056/nejmc2032195